Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Rhabdomyosarcoma is the most common soft tissue sarcoma in pediatrics and infants are reported to have inferior outcomes. ARST1431 recommended delayed primary excision (DPE) while discouraging radiation (RT) deviations. This analysis compared outcomes among very young and older patients in this study. PROCEDURES: Demographic and tumor characteristics were summarized using frequencies and percentages. Local failure (LF) frequency was summarized by age group, RT, and DPE status. Event-free survival (EFS) and overall survival (OS) were estimated using the Kaplan-Meier method and compared between age groups using the log-rank test. RESULTS: Of 296 patients, 48 (16.2%) were
Fields of Study & Subjects
Sarcoma Diagnosis and Treatment
Acute Lymphoblastic Leukemia research
Childhood Cancer Survivors' Quality of Life
Publication details
- Journal / source
- Pediatric Blood & Cancer
- Volume
- 73
- Issue
- 6
- Pages
- e70293–e70293
- Publication date
- 31 March 2026
- Language
- EN